Cargando…
Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762]
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1310608/ http://dx.doi.org/10.1186/1471-244X-5-44 |
_version_ | 1782126311441956864 |
---|---|
author | Carey, Paul D Vythilingum, Bavanisha Seedat, Soraya Muller, Jacqueline E van Ameringen, Michael Stein, Dan J |
author_facet | Carey, Paul D Vythilingum, Bavanisha Seedat, Soraya Muller, Jacqueline E van Ameringen, Michael Stein, Dan J |
author_sort | Carey, Paul D |
collection | PubMed |
description | |
format | Text |
id | pubmed-1310608 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2005 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-13106082005-12-10 Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762] Carey, Paul D Vythilingum, Bavanisha Seedat, Soraya Muller, Jacqueline E van Ameringen, Michael Stein, Dan J BMC Psychiatry Correction BioMed Central 2005-11-30 /pmc/articles/PMC1310608/ http://dx.doi.org/10.1186/1471-244X-5-44 Text en Copyright © 2005 Carey et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Correction Carey, Paul D Vythilingum, Bavanisha Seedat, Soraya Muller, Jacqueline E van Ameringen, Michael Stein, Dan J Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762] |
title | Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762] |
title_full | Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762] |
title_fullStr | Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762] |
title_full_unstemmed | Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762] |
title_short | Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762] |
title_sort | quetiapine augmentation of sris in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [isrctn83050762] |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1310608/ http://dx.doi.org/10.1186/1471-244X-5-44 |
work_keys_str_mv | AT careypauld quetiapineaugmentationofsrisintreatmentrefractoryobsessivecompulsivedisorderadoubleblindrandomisedplacebocontrolledstudyisrctn83050762 AT vythilingumbavanisha quetiapineaugmentationofsrisintreatmentrefractoryobsessivecompulsivedisorderadoubleblindrandomisedplacebocontrolledstudyisrctn83050762 AT seedatsoraya quetiapineaugmentationofsrisintreatmentrefractoryobsessivecompulsivedisorderadoubleblindrandomisedplacebocontrolledstudyisrctn83050762 AT mullerjacquelinee quetiapineaugmentationofsrisintreatmentrefractoryobsessivecompulsivedisorderadoubleblindrandomisedplacebocontrolledstudyisrctn83050762 AT vanameringenmichael quetiapineaugmentationofsrisintreatmentrefractoryobsessivecompulsivedisorderadoubleblindrandomisedplacebocontrolledstudyisrctn83050762 AT steindanj quetiapineaugmentationofsrisintreatmentrefractoryobsessivecompulsivedisorderadoubleblindrandomisedplacebocontrolledstudyisrctn83050762 |